Subcutaneous injections of platelet-rich plasma into skin flaps modulate proangiogenic gene expression and improve survival rates.

MLA

Li, Weiwei, et al. “Subcutaneous Injections of Platelet-Rich Plasma into Skin Flaps Modulate Proangiogenic Gene Expression and Improve Survival Rates.” Plastic and Reconstructive Surgery, vol. 129, no. 4, Apr. 2012, pp. 858–66. EBSCOhost, https://doi.org/10.1097/PRS.0b013e3182450ac9.

APA

Li, W., Enomoto, M., Ukegawa, M., Hirai, T., Sotome, S., Wakabayashi, Y., Shinomiya, K., & Okawa, A. (2012). Subcutaneous injections of platelet-rich plasma into skin flaps modulate proangiogenic gene expression and improve survival rates. Plastic and Reconstructive Surgery, 129(4), 858–866. https://doi.org/10.1097/PRS.0b013e3182450ac9

Chicago

Li, Weiwei, Mitsuhiro Enomoto, Madoka Ukegawa, Takashi Hirai, Shinichi Sotome, Yoshiaki Wakabayashi, Kenichi Shinomiya, and Atsushi Okawa. 2012. “Subcutaneous Injections of Platelet-Rich Plasma into Skin Flaps Modulate Proangiogenic Gene Expression and Improve Survival Rates.” Plastic and Reconstructive Surgery 129 (4): 858–66. doi:10.1097/PRS.0b013e3182450ac9.